BioSpace News Archive

The American Association of Critical-Care Nurses, Aliso Viejo, California, recently conferred a silver-level Beacon Award for Excellence in critical care at Huntington Hospital, Pasadena.

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the closing of an underwritten public offering of 6,808,154 shares of its common stock at a public offering price of $39.00 per share.

AbbVie, a research-based global biopharmaceutical company, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.

For the first time, Americans will have access to at-home testing for COVID-19 through Vault Health, utilizing the first FDA EUA approved saliva test from RUCDR Infinite Biologics and Spectrum Solutions.

Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today reported its financial results for the first quarter ended March 31, 2020 and provided an update on the company’s operations.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company developing novel therapeutics to treat chronic, high-prevalence retinal diseases, announced that it will host a business highlights webcast on Tuesday, May 12, 2020 at 1:30 p.m. Pacific Time.

Providers to benefit from free access to leading payer-provider collaboration platform through May

AIkido Pharma Inc. announced that Hoth Therapeutics Inc. registered the stock to be distributed on April 3 2020.

Kaplan Fox & Kilsheimer LLP is investigating claims on behalf of investors of CNS Pharmaceuticals, Inc.

Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.'s THERMOCOOL SMARTTOUCH® SF Ablation Catheter, evaluated in the PRECEPT study for the treatment of persistent atrial fibrillation (AF), resulted in freedom from any documented, symptomatic atrial arrhythmias at 15 months post-procedure for eight out of ten study participants (80.4 percent